PDE5A Destabilizing Domains for Rapid Protein Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modulating protein levels in cells are laborious, indirect, and often plagued by incomplete knockdown, off-target specificity, and long experimental delays, as they primarily target DNA or RNA, rather than directly controlling protein stability.
Innovation Solution
Development of novel protein domains, specifically destabilizing domains derived from human PDE5A, which are conditionally stable and can be regulated by small molecule ligands, allowing for rapid and reversible control of protein stability and function by fusion with a protein of interest.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If DNA or RNA targeting methods are used to modulate protein levels, then gene knockdown can be achieved, but experimental delays occur due to the intrinsic half-life of targeted proteins and incomplete knockdown efficiency
Solution Approach 1:
The invention extracts the essential function of protein degradation from indirect DNA/RNA targeting methods and implements it directly through destabilizing domains that recruit the ubiquitin-proteasome system to specifically degrade the protein of interest, bypassing the time-consuming transcriptional and translational processes
Solution Approach 2:
The destabilizing domain acts as an intermediary component that bridges the small molecule ligand and the protein of interest, enabling direct control of protein stability through ligand-induced recruitment of degradation machinery without affecting gene expression
2Reliability
If RNAi is used to silence genes, then protein levels can be reduced, but off-target specificity and incomplete knockdown plague this approach
Solution Approach 1:
The invention segments the control of protein levels from gene expression regulation by using a separate destabilizing domain module that can be independently controlled through small molecule ligands, eliminating cross-talk and off-target effects associated with RNAi mechanisms
Solution Approach 2:
The destabilizing domain serves as a specific intermediary that physically links the small molecule ligand to the protein of interest through genetic fusion, ensuring that only the intended target protein is affected by the ligand treatment
3Speed
If direct protein control methods are implemented, then rapid modulation of protein stability is achieved, but system complexity increases due to the need for destabilizing domains and ligand systems
Solution Approach 1:
The destabilizing domain is designed as a universal module that can be genetically fused to any protein of interest to confer ligand-controlled instability, making the system broadly applicable without requiring protein-specific customization beyond the fusion step
Solution Approach 2:
The system exploits parameter changes in protein stability through ligand binding, where the small molecule ligand induces a conformational or functional change in the destabilizing domain that switches the protein from a stable to an unstable state, enabling rapid modulation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables precise and rapid modulation of protein stability and function, minimizing experimental delays and specificity issues, with the ability to conditionally stabilize or destabilize proteins, allowing for detailed study of biological functions.
Implementation Method 1
approaches that directly recruit enzymes involved in the ubiquitin-proteasome system (UPS) to the protein of interest (POI), thereby promoting its degradation
Implementation Method 2
The high affinity ligand binds to and stabilizes the DD in a dose dependent manner
Data Source
AI summary
Disclosed herein are systems, methods, and compositions for rapidly and reversibly destabilizing a target protein in vitro or in vivo, in the presence or absence of a cell-permeable, synthetic molecule or ligand.